Form 4: Artivion CCO Sells Shares After Option Exercise

Artivion's Chief Commercial Officer, John E. Davis, exercised stock options and subsequently sold shares of common stock in planned transactions.

Summary

• John E. Davis, Chief Commercial Officer of ARTIVION, INC. (AORT), reported transactions involving the exercise of stock options and the subsequent sale of common stock.
• On November 14, 2025, Mr. Davis acquired 6,393 shares of common stock by exercising options at a price of $29.62 per share and then sold these 6,393 shares at $44.67 per share.
• On November 17, 2025, Mr. Davis acquired an additional 6,394 shares of common stock by exercising options at $29.62 per share and subsequently sold these 6,394 shares at $45.17 per share.
• All reported transactions were executed pursuant to a Rule 10b5-1 trading plan adopted by Mr. Davis on August 14, 2025.
• Following these transactions, Mr. Davis's direct beneficial ownership of Artivion common stock stands at 198,842 shares.

Sentiment

Score: 5

Explanation: The transactions are routine insider sales executed under a pre-arranged 10b5-1 plan, which typically minimizes sentiment impact as they are not indicative of new information or a change in management's outlook.

Positives

• The Chief Commercial Officer realized a profit by exercising stock options at a lower price ($29.62) and selling shares at significantly higher market prices ($44.67 and $45.17).
• The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a structured approach to managing personal equity holdings rather than an immediate reaction to market conditions.

Negatives

• The Chief Commercial Officer's direct beneficial ownership of common stock decreased by a total of 12,787 shares (6,393 + 6,394) as a result of these sales.

Risks

• No specific risks are disclosed in this insider transaction report, as Form 4 filings are purely transactional and do not typically contain risk factor discussions.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This insider transaction report does not provide information relevant to broader industry trends or competitive analysis.

Stakeholder Impact

• Shareholders: The sale of shares by a key officer results in a minor reduction in insider ownership, which is generally neutral given the pre-arranged nature of the 10b5-1 plan.
• Employees: No direct impact on employees is indicated by this filing.

Next Steps

• No specific future actions, events, or milestones are mentioned in this Form 4 filing.

Key Dates

Recommendation

The Form 4 reports routine insider transactions executed under a pre-arranged 10b5-1 trading plan. Such planned sales are generally not considered a strong indicator of future stock performance and do not warrant a change in investment recommendation based solely on this filing. Investors should consider broader company fundamentals and market conditions.

Keywords

Artivion, AORT, Form 4, Insider Trading, Stock Options, Share Sale, John E. Davis, Chief Commercial Officer, 10b5-1 Plan